Abstract
Long thought to be too big and too ubiquitous to fail, we now know that human cells can fail to make sufficient amounts of ribosomes, causing a number of diseases collectively known as ribosomopathies. The best characterized ribosomopathies, with the exception of Treacher Collins syndrome, are inherited bone marrow failure syndromes, each of which has a marked increase in cancer predisposition relative to the general population. Although rare, emerging data reveal that the inherited bone marrow failure syndromes may be underdiagnosed on the basis of classical symptomology, leaving undiagnosed patients with these syndromes at an elevated risk of cancer without adequate counselling and surveillance. The link between the inherited ribosomopathies and cancer has led to greater awareness that somatic mutations in factors involved in ribosome biogenesis may also be drivers in sporadic cancers. Our goal here is to compare and contrast the pathophysiological mechanisms underpinning ribosomopathies to gain a better understanding of the mechanisms that predispose these disorders to cancer.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Luzzatto, L. & Karadimitris, A. Dyskeratosis and ribosomal rebellion. Nat. Genet. 19, 6–7 (1998).
Dianzani, I. & Loreni, F. Diamond-Blackfan anemia: a ribosomal puzzle. Haematologica 93, 1601–1604 (2008).
Alter, B. P. et al. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br. J. Haematol. 150, 179–188 (2010).
De Keersmaecker, K. et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat. Genet. 45, 186–190 (2013).
Kressler, D., Hurt, E. & Bassler, J. A. Puzzle of life: crafting ribosomal subunits. Trends Biochem. Sci. 42, 640–654 (2017).
Reichow, S. L. et al. The structure and function of small nucleolar ribonucleoproteins. Nucleic Acids Res. 35, 1452–1464 (2007).
Ban, N. et al. A new system for naming ribosomal proteins. Curr. Opin. Struct. Biol. 24, 165–169 (2014).
Zhang, J. et al. Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and ribosomal proteins rpL5 and rpL11 into nascent ribosomes. Genes Dev. 21, 2580–2592 (2007).
Leidig, C. et al. 60S ribosome biogenesis requires rotation of the 5S ribonucleoprotein particle. Nat. Commun. 5, 3491 (2014).
Vlachos, A. et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br. J. Haematol. 142, 859–876 (2008).
Clinton, C. & Gazda, H. T. in GeneReviews® (eds Adam, M. P., Ardinger, H. H. & Pagon, R. A.) (University of Washington, Seattle, 2009).
Ikeda, F. et al. Exome sequencing identified RPS15A as a novel causative gene for Diamond-Blackfan anemia. Haematologica 102, e93–e96 (2017).
Mirabello, L. et al. Novel and known ribosomal causes of Diamond-Blackfan anaemia identified through comprehensive genomic characterisation. J. Med. Genet. 54, 417–425 (2017).
Orfali, K. A., Ohene-Abuakwa, Y. & Ball, S. E. Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneity. Br. J. Haematol. 125, 243–252 (2004).
Khajuria, R. K. et al. Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis. Cell 173, 90–103 (2018).
Flygare, J. et al. Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood 109, 980–986 (2007).
Choesmel, V. et al. Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood 109, 1275–1283 (2007).
Ebert, B. L. et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 451, 335–339 (2008).
Boocock, G. R. et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat. Genet. 33, 97–101 (2003).
Warren, A. J. Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome. Adv. Biol. Regul. 67, 109–127 (2018).
Stepensky, P. et al. Mutations in EFL1, an SBDS partner, are associated with infantile pancytopenia, exocrine pancreatic insufficiency and skeletal anomalies in a Shwachman-Diamond like syndrome. J. Med. Genet. 54, 558–566 (2017).
Dhanraj, S. et al. Biallelic mutations in DNAJC21 cause Shwachman-Diamond syndrome. Blood 129, 1557–1562 (2017).
Savage, S. A. et al. in GeneReviews® (eds Adam, M. P., Ardinger, H. H. & Pagon, R. A.) (University of Washington, Seattle, 2009).
Heiss, N. S. et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19, 32–38 (1998).
Ge, J. et al. Dyskerin ablation in mouse liver inhibits rRNA processing and cell division. Mol. Cell Biol. 30, 413–422 (2010).
Yoon, A. et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312, 902–906 (2006).
Bertuch, A. A. The molecular genetics of the telomere biology disorders. RNA Biol. 13, 696–706 (2016).
Thumati, N. R. et al. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation. Hum. Mutat. 34, 1698–1707 (2013).
Thiel, C. T. & Rauch, A. The molecular basis of the cartilage-hair hypoplasia-anauxetic dysplasia spectrum. Best Pract. Res. Clin. Endocrinol. Metab. 25, 131–142 (2011).
Ridanpaa, M. et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 104, 195–203 (2001).
Goldfarb, K. C. & Cech, T. R. Targeted CRISPR disruption reveals a role for RNase MRP RNA in human preribosomal RNA processing. Genes Dev. 31, 59–71 (2017).
Gill, T. et al. RNase MRP cleaves the CLB2 mRNA to promote cell cycle progression: novel method of mRNA degradation. Mol. Cell Biol. 24, 945–953 (2004).
Topper, J. N., Bennett, J. L. & Clayton, D. A. A role for RNAase MRP in mitochondrial RNA processing. Cell 70, 16–20 (1992).
Thiel, C. T. et al. Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum. Am. J. Hum. Genet. 81, 519–529 (2007).
Pestov, D. G., Strezoska, Z. & Lau, L. F. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol. Cell Biol. 21, 4246–4255 (2001).
Danilova, N., Sakamoto, K. M. & Lin, S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 112, 5228–5237 (2008).
Jaako, P. et al. Disruption of the 5S RNP-Mdm2 interaction significantly improves the erythroid defect in a mouse model for Diamond-Blackfan anemia. Leukemia 29, 2221–2229 (2015).
Dutt, S. et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 117, 2567–2576 (2011).
McGowan, K. A. et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat. Genet. 40, 963–970 (2008).
Marechal, V. et al. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell Biol. 14, 7414–7420 (1994).
Lohrum, M. A. et al. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3, 577–587 (2003).
Dai, M. S. & Lu, H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 279, 44475–44482 (2004).
Zhang, Y. et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol. Cell Biol. 23, 8902–8912 (2003).
Xu, X., Xiong, X. & Sun, Y. The role of ribosomal proteins in the regulation of cell proliferation, tumorigenesis, and genomic integrity. Sci. China Life Sci. 59, 656–672 (2016).
Donati, G. et al. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint. Cell Rep. 4, 87–98 (2013).
Sloan, K. E., Bohnsack, M. T. & Watkins, N. J. The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress. Cell Rep. 5, 237–247 (2013).
Pelava, A., Schneider, C. & Watkins, N. J. The importance of ribosome production, and the 5S RNP-MDM2 pathway, in health and disease. Biochem. Soc. Trans. 44, 1086–1090 (2016).
Nicolas, E. et al. Involvement of human ribosomal proteins in nucleolar structure and p53-dependent nucleolar stress. Nat. Commun. 7, 11390 (2016).
Fumagalli, S. et al. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat. Cell Biol. 11, 501–508 (2009).
Gazda, H. T. et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am. J. Hum. Genet. 83, 769–780 (2008).
Teng, T. et al. Loss of tumor suppressor RPL5/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity. Mol. Cell Biol. 33, 4660–4671 (2013).
Mills, E. W. & Green, R. Ribosomopathies: there’s strength in numbers. Science 358, eaan2755 (2017).
Ludwig, L. S. et al. Altered translation of GATA1 in Diamond-Blackfan anemia. Nat. Med. 20, 748–753 (2014).
Gastou, M. et al. The severe phenotype of Diamond-Blackfan anemia is modulated by heat shock protein 70. Blood Adv. 1, 1959–1976 (2017).
Horos, R. et al. Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts. Blood 119, 262–272 (2012).
Yang, Z. et al. Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome. Sci. Transl Med. 8, 338ra67 (2016).
Jack, K. et al. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol. Cell 44, 660–666 (2011).
Bellodi, C., Kopmar, N. & Ruggero, D. Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J. 29, 1865–1876 (2010).
Vlachos, A. et al. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood 119, 3815–3819 (2012).
Alter, B. P. et al. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica 103, 30–39 (2018).
Donadieu, J. et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 90, 45–53 (2005).
Vlachos, A. et al. Increased risk of colon cancer and osteogenic sarcoma in Diamond Blackfan anemia. Blood 132, 2205–2208 (2018).
Vlachos, A. et al. Increased prevalence of congenital heart disease in children with Diamond Blackfan anemia suggests unrecognized Diamond Blackfan anemia as a cause of congenital heart disease in the general population: a report of the Diamond Blackfan Anemia Registry. Circ. Genom. Precis Med. 11, e002044 (2018).
Lindsley, R. C. et al. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation. N. Engl. J. Med. 376, 536–547 (2017).
Taskinen, M. et al. Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma. Am. J. Med. Genet. A 146A, 2370–2375 (2008).
Fancello, L. et al. The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types. Oncotarget 8, 14462–14478 (2017).
Hofman, I. J. F. et al. RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response. Leukemia 31, 1706–1714 (2017).
Vlachos, A. Acquired ribosomopathies in leukemia and solid tumors. Hematol. Am. Soc. Hematol. Educ. Program 2017, 716–719 (2017).
Nieminen, T. T. et al. Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency. Gastroenterology 147, 595–598 (2014).
Rao, S. et al. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood 120, 3764–3773 (2012).
Kondrashov, N. et al. Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell 145, 383–397 (2011).
Zhang, Y. et al. Ribosomal proteins Rpl22 and Rpl22l1 control morphogenesis by regulating pre-mRNA splicing. Cell Rep. 18, 545–556 (2017).
Elghetany, M. T. & Alter, B. P. p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia. Arch. Pathol. Lab Med. 126, 452–455 (2002).
Jones, N. C. et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat. Med. 14, 125–133 (2008).
Fok, W. C. et al. p53 mediates failure of human definitive hematopoiesis in dyskeratosis congenita. Stem Cell Rep. 9, 409–418 (2017).
Marcel, V., Nguyen Van Long, F. & Diaz, J. J. 40 Years of research put p53 in translation. Cancers (Basel) 10, E152 (2018).
Ajore, R. et al. Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations. EMBO Mol. Med. 9, 498–507 (2017).
Xia, J. et al. Somatic mutations and clonal hematopoiesis in congenital neutropenia. Blood 131, 408–416 (2018).
Kulasekararaj, A. G. et al. TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis. Br. J. Haematol. 160, 660–672 (2013).
Scharenberg, C. et al. Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations. Haematologica 102, 498–508 (2017).
Ruggero, D. & Pandolfi, P. P. Does the ribosome translate cancer? Nat. Rev. Cancer 3, 179–192 (2003).
Lodish, H. F. Model for the regulation of mRNA translation applied to haemoglobin synthesis. Nature 251, 385–388 (1974).
Sulima, S. O. & De Keersmaecker, K. Ribosomal proteins: a novel class of oncogenic drivers. Oncotarget 8, 89427–89428 (2017).
Sulima, S. O. et al. Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis. Proc. Natl Acad. Sci. USA 111, 5640–5645 (2014).
Weis, F. et al. Mechanism of eIF6 release from the nascent 60S ribosomal subunit. Nat. Struct. Mol. Biol. 22, 914–919 (2015).
Dameshek, W. Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and “hypoplastic” leukemia have in common? Blood 30, 251–254 (1967).
De Keersmaecker, K., Sulima, S. O. & Dinman, J. D. Ribosomopathies and the paradox of cellular hypo- to hyperproliferation. Blood 125, 1377–1382 (2015).
Orgel, L. E. The maintenance of the accuracy of protein synthesis and its relevance to ageing. Proc. Natl Acad. Sci. USA 49, 517–521 (1963).
Bursac, S. et al. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc. Natl Acad. Sci. USA 109, 20467–20472 (2012).
Turi, Z. et al. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells. Cell Cycle 17, 92–101 (2018).
Grummt, I. Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev. 17, 1691–1702 (2003).
Albert, B. et al. A molecular titration system coordinates ribosomal protein gene transcription with ribosomal RNA synthesis. Mol. Cell 64, 720–733 (2016).
Sakai, D. & Trainor, P. A. Face off against ROS: Tcof1/Treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development. Dev. Growth Differ. 58, 577–585 (2016).
Juli, G. et al. Depletion of ribosomal protein S19 causes a reduction of rRNA synthesis. Sci. Rep. 6, 35026 (2016).
Doulatov, S. et al. Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors. Sci. Transl Med. 9, eaah5645 (2017).
Schaechter, M., Maaloe, O. & Kjeldgaard, N. O. Dependency on medium and temperature of cell size and chemical composition during balanced grown of Salmonella typhimurium. J. Gen. Microbiol. 19, 592–606 (1958).
Polymenis, M. & Schmidt, E. V. Coordination of cell growth with cell division. Curr. Opin. Genet. Dev. 9, 76–80 (1999).
Schmidt, E. V. The role of c-myc in cellular growth control. Oncogene 18, 2988–2996 (1999).
Chan, J. C. et al. AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer. Sci. Signal. 4, ra56 (2011).
Woods, S. J. et al. The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy. Biochim. Biophys. Acta 1849, 821–829 (2015).
Sulima, S. O. et al. How ribosomes translate cancer. Cancer Discov. 7, 1069–1087 (2017).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02719977 (2018).
Lee, H. C. et al. RNA polymerase I inhibition with CX-5461 as a novel therapeutic strategy to target MYC in multiple myeloma. Br. J. Haematol. 177, 80–94 (2017).
Lawrence, M. G. et al. Patient-derived models of abiraterone- and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy. Eur. Urol. 74, 562–572 (2018).
Hein, N. et al. Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population. Blood 129, 2882–2895 (2017).
Vincent, M. et al. Treacher Collins syndrome: a clinical and molecular study based on a large series of patients. Genet. Med. 18, 49–56 (2016).
Wise, C. A. et al. TCOF1 gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins syndrome throughout its coding region. Proc. Natl Acad. Sci. USA 94, 3110–3115 (1997).
Dauwerse, J. G. et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat. Genet. 43, 20–22 (2011).
Lipton, J. M. & Ellis, S. R. Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol. Oncol. Clin. North Am. 23, 261–282 (2009).
Gripp, K. W. et al. Diamond-Blackfan anemia with mandibulofacial dystostosis is heterogeneous, including the novel DBA genes TSR2 and RPS28. Am. J. Med. Genet. A 164A, 2240–2249 (2014).
Montellese, C. et al. Poly(A)-specific ribonuclease is a nuclear ribosome biogenesis factor involved in human 18S rRNA maturation. Nucleic Acids Res. 45, 6822–6836 (2017).
Nousbeck, J. et al. Alopecia, neurological defects, and endocrinopathy syndrome caused by decreased expression of RBM28, a nucleolar protein associated with ribosome biogenesis. Am. J. Hum. Genet. 82, 1114–1121 (2008).
Marneros, A. G. BMS1 is mutated in aplasia cutis congenita. PLOS Genet. 9, e1003573 (2013).
Meyer, B. et al. The Bowen-Conradi syndrome protein Nep1 (Emg1) has a dual role in eukaryotic ribosome biogenesis, as an essential assembly factor and in the methylation of Psi1191 in yeast 18S rRNA. Nucleic Acids Res. 39, 1526–1537 (2011).
Bolze, A. et al. Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia. Science 340, 976–978 (2013).
Jenkinson, E. M. et al. Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts. Nat. Genet. 48, 1185–1192 (2016).
Paolini, N. A. et al. A ribosomopathy reveals decoding defective ribosomes driving human dysmorphism. Am. J. Hum. Genet. 100, 506–522 (2017).
Reviewer information
Nature Reviews Cancer thanks D. Lafontaine, L. Montanaro and the other anonymous reviewer(s) for their contribution to the peer review of this work.
Author information
Authors and Affiliations
Contributions
Both authors contributed equally to this work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Glossary
- 2'-O-methylation
-
The addition, mostly found in pre-rRNA, of a methyl group at the 2' position of the ribose by ribonucleoprotein complexes containing C/D box family small nucleolar RNA.
- Pseudouridylation
-
The isomerization of uridine due to a 180° rotation for which the uracil is attached to the ribose via a carbon–carbon instead of a nitrogen–carbon glycosidic bond.
- Myelodysplastic syndrome
-
A heterogeneous group of clonal disorders characterized by ineffective haematopoiesis and cytopenias that may evolve into acute myeloid leukaemia.
- Metaphyseal chondrodysplasia
-
A defective bone development causing short stature.
Rights and permissions
About this article
Cite this article
Aspesi, A., Ellis, S.R. Rare ribosomopathies: insights into mechanisms of cancer. Nat Rev Cancer 19, 228–238 (2019). https://doi.org/10.1038/s41568-019-0105-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-019-0105-0
This article is cited by
-
Identification of genes related to ribosomal proteins in colorectal cancer: exploring their potential as biomarkers, prognostic indicators, and therapeutic targets
Molecular Biology Reports (2024)
-
Visualizing the nucleoplasmic maturation of human pre-60S ribosomal particles
Cell Research (2023)
-
Genetics of human telomere biology disorders
Nature Reviews Genetics (2023)
-
FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex
Cell Communication and Signaling (2022)
-
RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis
Cell Death & Differentiation (2022)